Nabriva Therapeutics (NASDAQ:NBRV) Stock Passes Above Fifty Day Moving Average – Here’s What Happened

Nabriva Therapeutics plc (NASDAQ:NBRV) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.00 and traded as high as $0.00. Nabriva Therapeutics shares last traded at $0.00, with a volume of 0 shares.

Wall Street Analysts Forecast Growth

Separately, StockNews.com began coverage on shares of Nabriva Therapeutics in a report on Friday. They issued a “hold” rating on the stock.

Nabriva Therapeutics Stock Performance

The company has a current ratio of 0.85, a quick ratio of 0.52 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $45.46 million, a PE ratio of 0.00 and a beta of 1.53.

About Nabriva Therapeutics

Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for oral and IV administration.